Topic-Contributed Paper Session
Decentralized Trials for Rare Diseases: What are the Benefits and Risks?
WNAR
3 Presentations
2:05 PM - 2:25 PM
Mercedeh Ghadessi (Bayer Healthcare)
2:25 PM - 2:45 PM
Kit Roes (European Medicines Agency, Radbound University, The Netherlands)
Discussant
Kun Jin (Anavex Corp)